Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by gdown9on Nov 13, 2018 3:44pm
102 Views
Post# 28967630

RE:Technically

RE:Technically
INVSTIGAT0R wrote: If the Constellations deal never happened for Canopy in August but an Altria deal did on the exact same day, at the same 50% premium that Canopy got then the deal that Aphria would have closed would have been at the price of about $13.50 per share. Altria and Diageo knows this obviously. They can do simple math. I'm starting to think that we were all beyond stupid to think that the Constellations deal + Legalization hype that drove us from $8.xx to $22.xx would have somehow convinced a big company to give us a premium on top of all that. $30? Really? I'm feeling pretty stupid myself. Now I don't think we deserve a 50% premium trading at $8-$9 because we are very undervalued, but I think now that we're a lot closer to big numbers I think a $20-$24 sounds about right for a deal if it's made soon.

Maybe Vic is softbashing constantly to bring the share price down futher so he doesn't look so bad? If he closed a deal at $20 when it was at $17 the market would not like that one bit. But if he closes a deal at $20 when the share price is $13, oh look the headline reads 50%+ premium instead of like 15%+.

If you're unhappy that Canopy got a big deal and we didn't remember this:

WE DID (essentially). We gained more than 100% in less than 1 month. That is effectively the same outcome as Aphria getting a deal at the same time Canopy did. So stop all your b.itching and realize that you just simply made an investment error and have to hold a bit longer, thats all. Aphria is great. Aphria will get a deal, it won't be $30 (likely somewhere in the $20-$24 area). There is endless growth ahead in this industry so just hold and forget it. Aphria will be a big player and will easily boast a 10-20 billion+ market cap in a few years.   


$20-$24 look good now.  Done deal! :-)

Bullboard Posts